Pfizer Inc. (PFE) Social Stream
Pfizer Inc (PFE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PFE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 11 | $61 | $41 | $47.6 | $52.74 | -9.75% |
| 2021-11-14 | 10 | $61 | $41 | $47.6 | $52.74 | -9.75% |
| 2021-11-19 | 11 | $61 | $41 | $48.727 | $52.74 | -7.61% |
| 2021-11-23 | 11 | $61 | $41 | $50.09 | $52.74 | -5.02% |
| 2021-11-29 | 11 | $61 | $41 | $51.09 | $52.74 | -3.13% |
| 2021-12-09 | 12 | $61 | $41 | $52.666 | $52.74 | -0.14% |
| 2021-12-14 | 14 | $61 | $41 | $54.642 | $52.74 | 3.61% |
| 2021-12-15 | 14 | $61 | $41 | $55.214 | $52.74 | 4.69% |
| 2021-12-17 | 13 | $75 | $41 | $56.214 | $52.74 | 6.59% |
| 2022-01-04 | 13 | $75 | $41 | $57.571 | $52.74 | 9.16% |
| 2022-01-05 | 13 | $75 | $41 | $58.357 | $52.74 | 10.65% |
| 2022-01-24 | 12 | $75 | $41 | $58.923 | $52.74 | 11.72% |
| 2022-01-28 | 12 | $75 | $41 | $59.23 | $52.74 | 12.31% |
| 2022-02-09 | 12 | $75 | $44 | $60.75 | $52.74 | 15.19% |
| 2022-03-23 | 12 | $75 | $44 | $60.666 | $52.74 | 15.03% |
The Trend in the Analyst Price Target
PFE's average price target has moved up $17.7 over the prior 37 weeks.
Over the past 51 weeks, PFE's average upside potential has been 5.46%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-03 | 2 | 53 | 36 | 40.540 | 36.30 | 11.68% |
| 2021-09-18 | 24 | 61 | 38 | 46.030 | 43.89 | 4.88% |
| 2021-11-14 | 11 | 61 | 41 | 47.600 | 49.73 | -4.28% |
| 2021-12-14 | 14 | 61 | 41 | 54.642 | 55.54 | -1.62% |
| 2022-02-08 | 12 | 75 | 44 | 60.750 | 51.70 | 17.5% |
PFE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 8 | 0 | 4 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 19 months, PFE's average broker recommendation rating improved by 0.53.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Pfizer Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 69.32% of that group.
- In terms of how Pfizer Inc fares relative to stocks in the mega market cap category, note that its average analyst price target is greater than 188.76% of that group.
- In terms of how Pfizer Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 1466.52% of that group.
- PFE has a lower variance in analysts' estimates than -926.46% of stocks in the mega market cap category.
In the Pharmaceutical Products industry, NVS, NVO, and MRK are the three stocks most similar to Pfizer Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding PFE using the data that counts. Try POWR Ratings for free.